Pharmalot By Ed Silverman As monkeypox spreads, Bavarian Nordic’s CEO is fielding calls for his vaccine, but doesn’t see panic
D.C. Diagnosis By Rachel Cohrs California senators advance three bills meant to crack down on health insurers
Biotech By Ryan Cross — The Boston Globe Flagship’s latest startup launches with bold claim: the discovery of thousands of new human proteins
Pharmalot By Ed Silverman Pharmalittle: Teva and Allergan reach $161 million opioid settlement with West Virginia; FDA lifts hold on Bharat Covid shot
Politics By Rachel Cohrs Key Senate panel wants to axe in-person requirement for virtual mental health services
Opinions+ By Emily Johnson and Jenna Phillips QR codes can help pharmaceutical companies in two big ways
Politics By Rachel Cohrs There may be a backdoor way for hospitals to get paid for uninsured Covid-19 care
Pharmalot By Ed Silverman Once-a-day pills for combating HIV are a better deal than some people think
Pharmalot By Ed Silverman Gilead’s HIV prevention pill can greatly reduce new infections in targeted rollouts
Health By Erin Mershon Insurer’s mailing to customers made HIV status visible through envelope window
Health By Helen Branswell Patient Zero in AIDS crisis was misidentified, study says, rewriting early history of virus
In the Lab By Shayla Love Genetic fossil-hunters dig through HIV’s long history for clues to new treatments
In the Lab By Andrew Joseph A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests
Heavyweights By Rebecca Robbins The drug pricing crusader at the center of one of the nastiest fights of the election season
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Another analysis finds new cholesterol drugs are not cost-effective
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Gilead’s preventive HIV pill must be covered in England
First Opinion By Peter Piot and Mitchell Warren Prevention must be at the forefront to meet global HIV goals
First Opinion By Anthony S. Fauci and Deborah L. Birx An AIDS-free world is possible, but do we have the will to achieve it?